Recently, HMGB1 has been identified as a late-phase inflammatory mediator in sepsis, persisting during prolonged inflammation and contributing to poor outcomes [8–12], while cytokines such as IL-6 act as early-phase mediators and play a key role in the cytokine storm associated with BM. Here, HMGB1 is linked to Sepsis.